| Names | |
|---|---|
| IUPAC name 1-(3-Bromo-5-isoxazolyl)-2-(tert-butylamino)ethanol | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.071.338 |
| MeSH | Broxaterol |
| UNII | |
| |
| |
| Properties | |
| C9H15BrN2O2 | |
| Molar mass | 263.135 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Broxaterol is aβ2 adrenoreceptor agonist.[1] It is part of a class ofdrugs that affect thesmooth muscle receptors in the body, often in use cases forrespiratory disease that respond to this type of treatment.
The1,3-dipolar cycloaddition between bromonitrile oxide, producedin situ from dibromoformaldoxime, and 3-butyn-2-one gives a mixture of isoxazoles, mainly theisomer shown required for broxaterol. Selective α-bromination of the acetyl group withpyridinium tribromide gives a bromoketone whosecarbonyl group is reduced withsodium borohydride to produce a bromoethanol derivative. Treatment of this withtert-butylamine yields broxaterol.[2][3][4][5]
Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byadding missing information. |